Skip to main content

A systematic review of multi-level stigma interventions: state of the science and future directions



Researchers have long recognized that stigma is a global, multi-level phenomenon requiring intervention approaches that target multiple levels including individual, interpersonal, community, and structural levels. While existing interventions have produced modest reductions in stigma, their full reach and impact remain limited by a nearly exclusive focus targeting only one level of analysis.


We conducted the first systematic review of original research on multi-level stigma-reduction interventions. We used the following eligibility criteria for inclusion: (1) peer-reviewed, (2) contained original research, (3) published prior to initiation of search on November 30, 2017, (4) evaluated interventions that operated on more than one level, and (5) examined stigma as an outcome. We stratified and analyzed articles by several domains, including whether the research was conducted in a low-, middle-, or high-income country.


Twenty-four articles met the inclusion criteria. The articles included a range of countries (low, middle, and high income), stigmatized conditions/populations (e.g., HIV, mental health, leprosy), intervention targets (e.g., people living with a stigmatized condition, health care workers, family, and community members), and stigma reduction strategies (e.g., contact, social marketing, counseling, faith, problem solving), with most using education-based approaches. A total of 12 (50%) articles examined community-level interventions alongside interpersonal and/or intrapersonal levels, but only 1 (4%) combined a structural-level intervention with another level. Of the 24 studies, only 6 (25%) were randomized controlled trials. While most studies (17 of 24) reported statistically significant declines in at least one measure of stigma, fewer than half reported measures of practical significance (i.e., effect size); those that were reported varied widely in magnitude and were typically in the small-to-moderate range.


While there has been progress over the past decade in the development and evaluation of multi-level stigma interventions, much work remains to strengthen and expand this approach. We highlight several opportunities for new research and program development.

Peer Review reports


Stigma can aggravate disease processes and add numerous socioeconomic, psychosocial, and health burdens on people who hold marginalized identities or statuses, including reduced educational attainment, exposure to psychosocial stressors, and challenges in accessing healthcare [1]. Behavioral scientists have studied the severe negative consequences of stigma for individuals coping with various health conditions and have learned that stigma can deter individuals from optimally engaging in treatment for their condition, which has serious impacts on morbidity and mortality [2]. Strikingly, when disease morbidity and mortality are low but the condition is highly stigmatized, the burden of stigma may exceed the burden of the disease in its impact on social, emotional, and work functioning, thus negatively affecting the overall quality of life [3]. Researchers have long recognized that stigma operates on intrapersonal, interpersonal, organizational, and structural levels, and as such, stigma is conceptualized as an inherently multi-level phenomenon [1]. The multi-level nature of stigma renders the development of stigma interventions particularly challenging, in part because addressing multiple levels through research is more complex, requires more resources, and may be more burdensome to participants than single-level interventions. However, for research teams willing to take on the task of addressing multiple levels, the impacts on stigma reduction efforts can be farther reaching, more synergistic, and more holistic than single-level interventions [4].

Two previous papers have reviewed the literature on stigma reduction interventions. In Heijnders and Van Der Meij’s 2006 review [5], consistent with the multi-level approach to stigma [1], the authors identified five levels of examination and mapped strategies and target populations directly onto each level. First, at the intrapersonal level, the focus of interventions is on characteristics of the individuals living with a stigmatized condition, and strategies involve self-help, counseling, and treatment. Second, at the interpersonal level, the intervention is focused on the enhancement of care and support in the stigmatized persons’ local environment. Third, at the community level, the focus is on reducing stigmatizing attitudes and behaviors in (non-stigmatized) community groups using strategies such as education, contact, and advocacy. Heijnders and Van Der Meij define contact as any interactions between the public and the affected person for the purpose of reducing stigma [5]. Fourth, at the organizational/institutional level, interventions focus on reducing stigma in an organization or institution, and strategies include training programs and institutional policies. Fifth, at the governmental/structural level, interventions focus on establishing and enforcing legal, policy, and rights-based structures.

In 2014, Cook and colleagues [6] conducted a narrative review that similarly considered multiple levels in which stigma interventions can operate as part of an ecological system [7], but focused on only three levels: intrapersonal, interpersonal, and structural. Cook et al.’s definitions of these levels differed slightly from those of Heijnders and Van Der Meij’s and were more flexible, in that one strategy, such as education, could operate on multiple levels. The authors’ primary purpose was to describe how each strategy operates on multiple levels, while targeting both stigmatized and non-stigmatized populations.

Although neither review was systematic, both challenged investigators to build and evaluate multi-level stigma reduction interventions. In Heijnders and Van Der Meij’s review [5], while all of the strategies reviewed had the potential to operate on multiple levels, the authors reviewed studies that evaluated stigma reduction strategies at a single level of analysis. In their conclusion, they called for researchers to combine multiple strategies to target multiple levels. Cook and colleagues [6] conducted an updated narrative review of stigma interventions and analyzed these studies for cascading impacts across multiple levels. The authors determined that studies examining cascading effects across levels were rare, concluding that stigma reduction interventions that examine effects across levels were urgently needed. While these two prior reviews pointed out important lacuna in the literature on stigma interventions, our study addresses another knowledge gap by conducting the first systematic review of multi-level stigma interventions. We describe the country of origin of research studies, depict the design and participants of each multi-level stigma intervention, discuss the strategies and outcomes used by these interventions, and highlight opportunities for new research and program development.


We conducted this review in accordance with the Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines [8]. We included studies that focused on stigma reduction interventions operating on multiple levels, both within and outside of the USA. The overall purpose of our review was descriptive, rather than evaluative. Thus, for each study, we provide a basic indication of effectiveness in reducing stigma, but a detailed evaluation of study effectiveness was beyond the scope of this review.

We used Heijnders and Van Der Meij’s categories for the levels of the ecological system (i.e., intrapersonal, interpersonal, community, organizational/institutional, governmental/structural) [5]. However, we expanded our organization of these predefined strategies (e.g., education, contact) such that they could map onto multiple levels, which Heijnders and Van Der Meij did not do in their analysis. For example, if one target of an intervention was to improve attitudes held, whether by the stigmatized or the non-stigmatized, we categorized this focus at the intrapersonal level. If an intervention’s target was to improve interactions between people with stigmatized conditions and other stakeholders (e.g., caregivers, healthcare workers), we categorized this focus at the interpersonal level. If the (non-stigmatized) public was targeted, we identified the community level as the focus. If an organization was targeted, we identified the organizational/institutional level as the focus. If a policy or administrative structure was targeted, we identified governmental/structural level as the focus.

Search terms

For our systematic review, we input search terms into six electronic database sources (PubMed, Embase, CINAHL, Global Health, Scopus, and PsychINFO). We looked for all papers with the term “stigma” plus at least one of the following terms: “intervention,” “program,” “programme,” or “policy” in either the title or abstract. We used the Covidence database [9] to extract and organize information from articles. Because of our focus on health-related stigmas, we used primarily health-based databases in our search.

Inclusion criteria

We used the following eligibility criteria for inclusion: (1) peer-reviewed, (2) contained original research, (3) published prior to initiation of search on November 30, 2017, (4) evaluated interventions that operate on more than one level, as defined above, and (5) examined stigma as an outcome.

Exclusion criteria

We excluded protocol papers, papers published in languages other than English, abstracts without full texts available, non-peer reviewed articles, and solely qualitative studies.

Data extraction

After identifying a list of all relevant records and removing duplicates, 10,621 titles remained for title, abstract, and full-text screening. The abstract/title review and subsequent full-text review of the selected studies were conducted independently by two investigators (AE and MN), who had approximately 99% agreement, disagreeing on only 39 of 10,621 articles. Discrepancies were resolved over discussions with two additional investigators (DR and VG). The investigators retained 138 articles after abstract screening and 24 articles after full-text screening based on the inclusion/exclusion criteria above. One hundred and fourteen articles were excluded during full-text screening because we found the articles met exclusion criteria only after reviewing the full text. This process is depicted in Fig. 1.

Fig. 1

Flow of article inclusion and exclusion from review

Data analysis

We used content analysis [10] to organize the selected qualifying studies. DR and SF independently coded each article. We read through each article and systematically created and collapsed categories. When SF and DR encountered discrepancies, the codes were discussed and adjusted by consensus and the levels, as presented above. The themes identified from the articles included the following: condition/population studied (e.g., HIV, mental health, substance use, leprosy, diabetes, epilepsy, orphaned and vulnerable children), intervention targets (e.g., people living with a condition, health care workers, caregivers/family members, community members), level of intervention targeted, country that served as the setting for the study, and stigma reduction strategies used in the interventions (e.g., education, contact, social marketing, counseling, faith, problem solving). We also coded articles for information on the intensity of the strategies used (e.g., duration, number of sessions) and whether the studies used validated stigma measures. We examined effectiveness using a simple, parsimonious approach, categorizing findings in terms of statistical significance (at least 1 measure of stigma used showed statistically significant reduction) or statistical non-significance (no statistical significance found or no inferential statistics used). We provided confidence intervals when given in the articles, and effect sizes if given or if enough information was given to calculate effect sizes in the articles.


Overall, six of the 24 studies were randomized controlled trials (two used individual randomization [11, 12] and four used cluster randomization [13,14,15,16]) (Table 1). Eighteen studies did not randomize or use a control group and thus were not considered randomized controlled trials (RCTs). Most studies reported on pilot trials of interventions. Of the studies reviewed that did use RCT designs, four used cluster randomization. All studies used convenience samples rather than population-based sampling.

Table 1 Multi-level stigma interventions

We found approximately equal numbers of studies originating from low- and middle-income country (LMIC) and high-income country (HIC) settings, with 13 studies conducted in HIC and 11 studies conducted in LMIC. Five studies were based in the US, three in the UK, two in Canada, two in Indonesia, two in South Africa, and one study spanned five African countries (Lesotho, Malawi, South Africa, Swaziland, and Tanzania). One study was conducted in each of the following countries: Kenya, Zambia, China, India, Vietnam, Israel, Haiti, Australia, and Japan.

Twelve articles examined stigma associated with mental illness, six HIV, two leprosy, one Moebius syndrome, and one each of epilepsy, orphans and vulnerable children, and substance use. Eighteen articles described studies targeting stigmatized participants, 12 included participants who were community members (e.g., students, police), six articles included healthcare workers as participants, eight articles addressed stigma among caregivers/family members, and two articles examined stigma among youth at risk for HIV. Of the articles targeting stigmatized populations, six studies targeted both stigmatized and community populations, eight studies targeted both stigmatized and caregiver populations, and six studies targeted both stigmatized and healthcare worker populations.

Five of the six articles examining HIV-related stigma originated from LMICs. Conversely, articles examining mental illness-related stigma predominantly came from a HIC (e.g., UK, US, Canada), with only one out of 12 articles from a LMIC (India). Five studies were published prior to 2010, whereas 19 were published between 2010 and 2017. Five of the six studies of HIV-related stigma were published after 2010, and nine of 12 studies of mental health-related stigma were published in 2010 or after.

The most common levels examined together were intrapersonal and interpersonal, with 15 articles including these two levels together. Of the 24 articles, four examined the community level alongside both the intrapersonal and interpersonal levels. Three articles examined intrapersonal and community levels together, and another three examined interpersonal and community levels together. Thus, a total of 10 articles examined community levels alongside either interpersonal, intrapersonal, or both levels. Only one article examined the institutional level (along with intrapersonal), and no articles targeted the structural level. Figure 2 depicts these findings, separated by LMIC and HIC study location.

Fig. 2

Levels examined together, separated by high- and low/middle-income country

The most common stigma reduction strategy studied was education, with 16 studies using this strategy. Ten studies examined contact, five counseling or coping skills acquisition, three social support, three drama, and two problem solving. Individual studies also examined communication skills, voluntary counseling and testing, psychiatric treatment, and outdoor adventure as stigma reduction techniques. Of the 12 articles that examined the community level alongside at least one other level, six used contact as a primary strategy. Eight studies used education and contact strategies together, and six of these eight studies originated from HIC.

Seven of the 24 studies examined one stigma reduction strategy across more than one level. For example, Patalay and colleagues [17] trained university medical students in the UK to lead workshops with secondary school students on mental health conditions and services (educational strategy). Investigators measured medical students’ levels of stigma and impact on the interpersonal level to examine the workshop leadership’s potential impact on medical students’ future practice behaviors. The researchers also measured attitudes towards mental illness of the recipients of the intervention, (the secondary school students), thereby using the same educational strategy and then assessing community-level stigma. Of note, one study used an educational strategy with specialized areas of content: Brown and colleagues [18] had nursing students deliver a stigma reduction program in the US to community members by providing information on mental health issues as well as on a faith-based framework for dealing with mental health issues. In other words, this intervention provided education on a condition as well as education on using faith to cope with the condition (two educational strategies), without using faith-based counseling techniques as the intervention itself.

The majority (16 of 24) of studies reviewed used stigma scales that were validated and used in multiple countries. The remaining eight studies used scales that were adapted from validated scales, used in a neighboring country, or validated by the study team for use in the country where the study had taken place. Beyond use of validated and adapted measures, the articles provided little information on how well the instruments performed across cultures and contexts.

In terms of effectiveness, 17 studies reported that their intervention reduced stigma scores (p < 0.05) on at least one measure of stigma and seven studies reported non-significant results. Of these seven studies that found non-significance, five were conducted in high-income countries and two were conducted in middle-income countries (China and South Africa). Only two of the 24 articles provided information on confidence intervals. In terms of practical significance, only 11 out of the 24 studies provided information to calculate effect sizes or the effect sizes themselves. Cohen’s d values that were reported ranged from 0.4 to 2.51, Eta squared and R-squared values ranged from 0.02 to 0.32, indicating small-to-moderate effects across studies.


We set out to review intervention studies that targeted multiple levels of stigma reduction and identified 24 studies. Notably, the majority of studies identified and reviewed were published after 2010, demonstrating an increasing urgency and movement in the research community towards developing and validating stigma reduction interventions. Articles that originated from HICs tended to examine mental illness-related stigma, whereas those from LMICs tended toward the examination of HIV-related stigma. This may be due to availability of funds, as global health spending in LMICs has decreased over time except for HIV-related work [19].

Most investigators used validated or adapted measures of stigma in their studies, but provided little information on how well the measures performed in diverse settings. Contextual psychometric information and sensitivity/specificity of measures are useful pieces of information to determine accurate interpretation of intervention effectiveness. This is particularly relevant for studies that used adapted measures or measures validated in languages or contexts that differed from where the studies were conducted. More detailed examination of measures used to evaluate intervention effectiveness will be an important direction for future research on multi-level interventions.

Similarly, we found relatively few studies that used randomized controlled trial (RCT) designs. The lack of RCT designs may be due to the challenges of conducting RCTs across multiple levels. Investigators in future studies of multi-level stigma interventions may consider use of non-traditional hybrid trial designs, quasi-experimental designs, or other types of pragmatic designs used in complex real-world settings. Similarly, we also noted that just under half of the reviewed articles provided effect sizes, and those that were reported varied widely in magnitude. Adding rigor to these designs may help to narrow information on the potential benefits of interventions that operate on multiple levels.

The intrapersonal and interpersonal levels were most often targeted by the multi-level stigma interventions studied, which may be due to several factors. The broader stigma literature has focused almost exclusively on these two levels of analysis [1]; thus, multi-level interventions have a larger evidence base from which to draw at these levels. Relatedly, research has accumulated a wealth of stigma measures at the individual/interpersonal levels of analysis. In contrast, until recently, fewer measures of stigma existed at community, organizational, and structural levels, which likely hindered the assessment of multi-level stigma interventions that incorporated communities and social structures [20]. This focus on the individual/interpersonal levels in multi-level stigma interventions may also be due to convenience—intervention studies are often easier to implement in clinical settings where people with health-related stigmatizing conditions seek care and where their family members (who are needed for research at the interpersonal level) are more easily identified and assessed. More research is needed to incorporate community-, organizational-, and structural-level influences into multi-level stigma interventions.

Approximately half the studies reviewed examined community-level stigma reduction, with intrapersonal and/or interpersonal levels. Studies that targeted community levels of stigma predominantly used methods of interaction, or contact, across populations studied, examining the impact of exchanging information and making use of bi-directional learning and including people living with stigmatized conditions in the process (e.g., teaching, drama). In addition, these studies tended to incorporate exchanges of support, particularly when family members and health care workers were involved.

Despite accumulating research indicating that structural forms of stigma contribute to adverse health outcomes among members of stigmatized groups [21, 22], only one study combined an institutional-level approach, and no studies combined the structural-level approach, alongside another level. Researchers may consider institutional- and structural-level interventions challenging, since they require time and financial resources to examine stigma in large samples. Despite these challenges, single-level studies are beginning to emerge that examine stigma reduction as a result of policy changes at the structural level [23]. Thus, one important direction for future development of multi-level interventions is greater attention to, and incorporation of, policy-level interventions to address stigma at the institutional and structural levels.

With respect to stigma-reduction strategies used by these multi-level stigma interventions, most focused on education, either alone or in combination with other strategies, such as contact. Corrigan and colleagues found over years of research that stand-alone educational programs can lead to stereotype suppression, in which members of the public suppress—rather than reject—stereotyped beliefs upon learning that such beliefs are socially undesirable [24, 25]. Thus, educational programs alone are often ineffective in reducing stigmatizing attitudes in members of the public, and the little resulting stigma reduction that occurs may be short-lived and superficial [26]. Future research on multi-level stigma interventions is therefore needed to explore a wider range of stigma-reduction strategies and to utilize evidence-based strategies that prior research has shown to be effective in reducing stigma.

This review has several limitations. First, although we introduced independent secondary article reviewers and coders, our process of article selection, non-inclusion of gray literature, inclusion of studies reported in English only, and content analysis may have introduced selection biases that restrict the generalizability of our findings to all multi-level stigma interventions. Second, the scope of our study did not include detailed comments regarding a methodological appraisal of studies and we included limited information on intervention effectiveness. The lack of rigor in these studies may have led to sampling bias and non-generalizable conclusions. Thus, additional research will need to be done before recommendations on effectiveness can be made.


Stigma is inherently a cross-sectoral phenomenon [1] and thus efforts to reduce stigma and its pernicious effects require a multi-level approach. Despite progress over the past decade in the development of multi-level stigma interventions, much work remains to strengthen and broaden this approach. In Table 2, we highlight several opportunities for new research and program development in multi-level stigma interventions, organized around several key domains (e.g., measurement, mechanisms of change, implementation). This list is not exhaustive, but rather is meant to underscore some of the most important areas of inquiry that are needed to advance the knowledge base in this incipient field. For instance, multi-level stigma interventions may not always be appropriate; future research is therefore needed to systematically compare the efficacy of single-level vs. multi-level stigma interventions in order to determine the conditions under which multi-level stigma interventions may be preferable to single-level interventions. Future research is also needed to evaluate how changes at one level of stigma (e.g., intrapersonal) impact other levels of stigma (e.g., community) in order to guide the development of more effective multi-level interventions, to identify mechanisms of change in multi-level stigma interventions, and to explore the barriers and facilitators to the dissemination of multi-level stigma interventions across diverse contexts. Only after answering these questions will it be possible to fully evaluate whether multi-level stigma interventions are effective in addressing the predicament of stigma in the lives of the stigmatized.

Table 2 Future directions for multi-level stigma interventions



Confidence interval


Effect size


Health care workers


High-income country


Human immunodeficiency virus


Low- and middle-income country


Mental illness


People living with HIV


Preferred Reporting Items for Systematic Reviews


People with


Randomized controlled trial


United States


  1. 1.

    Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013;103:813–21.

    Article  Google Scholar 

  2. 2.

    Treves-Kagan S, Steward WT, Ntswane L, et al. Why increasing availability of ART is not enough: a rapid, community-based study on how HIV-related stigma impacts engagement to care in rural South Africa. BMC Public Health. 2016;16:87.

    Article  Google Scholar 

  3. 3.

    Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52:1615–20.

    CAS  Article  Google Scholar 

  4. 4.

    Richman L, Hatzenbuehler ML. A multilevel analysis of stigma and health: implications for research and policy. Policy Instights Behav Brain Sci. 2014;1:213–21.

    Article  Google Scholar 

  5. 5.

    Heijnders M, Van Der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol Health Med. 2006;11:353–63.

    Article  Google Scholar 

  6. 6.

    Cook JE, Purdie-Vaughns V, Meyer IH, Busch JT. Intervening within and across levels: a multilevel approach to stigma and public health. Soc Sci Med. 2014;103:101–9.

    Article  Google Scholar 

  7. 7.

    Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. 1977;32:513–31.

    Article  Google Scholar 

  8. 8.

    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3:e123–30.

    PubMed  PubMed Central  Google Scholar 

  9. 9.

    Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at

  10. 10.

    Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398–405.

    Article  Google Scholar 

  11. 11.

    Michaels P, Corrigan P, Buchholz B, et al. Changing stigma through a consumer-based stigma reduction program. Community Ment Health J. 2014;50:395–401.

    Article  Google Scholar 

  12. 12.

    Ngoc TN, Weiss B, Trung LT. Effects of the family schizophrenia psychoeducation program for individuals with recent onset schizophrenia in Viet Nam. Asian J Psychiatr. 2016;22:162–6.

    CAS  Article  Google Scholar 

  13. 13.

    Jürgensen M, Sandøy IF, Michelo C, Fylkesnes K. Effects of home-based voluntary counselling and testing on HIV-related stigma: findings from a cluster-randomized trial in Zambia. Soc Sci Med. 2013;81:18.

    Article  Google Scholar 

  14. 14.

    Dadun D, Van Brakel WH, Peters RMH, et al. Impact of socio-economic development, contact and peer counselling on stigma against persons affected by leprosy in Cirebon, Indonesia--a randomised controlled trial.(Report). Lepr Rev. 2017;88:2.

    CAS  PubMed  Google Scholar 

  15. 15.

    Li L, Wu Z, Liang LJ, et al. An intervention targeting service providers and clients for methadone maintenance treatment in China: a cluster-randomized trial. Addiction. 2013;108:356–66.

    Article  Google Scholar 

  16. 16.

    Lusli M, Peters R, van Brakel W, et al. The impact of a rights-based counselling intervention to reduce stigma in people affected by leprosy in Indonesia.(Research Article)(Report). PLoS Negl Trop Dis. 2016;10:e0005088.

    Article  Google Scholar 

  17. 17.

    Patalay P, Annis J, Sharpe H, et al. A pre-post evaluation of OpenMinds: a sustainable, peer-led mental health literacy programme in universities and secondary schools. Prev Sci. 2017;18:995–1005.

    Article  Google Scholar 

  18. 18.

    Brown JF. Faith-based mental health education: a service-learning opportunity for nursing students. J Psychiatr Ment Health Nurs. 2009;16:581–8.

    CAS  Article  Google Scholar 

  19. 19.

    Institute for Health Metrics and Evaluation. Despite economic slump, donors give generously to global health, though at a slower rate. 2010. (Accessed 4 Apr 2018), at

  20. 20.

    Meyer I. Prejudice as stress: conceptual and measurement problems. Am J Public Health. 2003;93:262–5.

    Article  Google Scholar 

  21. 21.

    Hatzenbuehler M. Structural stigma: research evidence and implications for psychological science. Am Psychol. 2016;71:742–51.

    Article  Google Scholar 

  22. 22.

    Link B, Hatzenbuehler M. Stigma as an unrecognized determinant of population health: research and policy implications. J Health Polit Policy Law. 2016;41:653–73.

    Article  Google Scholar 

  23. 23.

    Pulerwitz J, Oanh KT, Akinwolemiwa D, Ashburn K, Nyblade L. Improving hospital-based quality of care by reducing HIV-related stigma: evaluation results from Vietnam. AIDS Behav. 2015;19:246–56.

    Article  Google Scholar 

  24. 24.

    Corrigan PW, Penn DL. Lessons from social psychology on discrediting psychiatric stigma. Am Psychol. 1999;54:765–76.

    CAS  Article  Google Scholar 

  25. 25.

    Penn D, Corrigan P. The effects of stereotype suppression on psychiatric stigma. Schizophr Res. 2002;55:269–76.

    Article  Google Scholar 

  26. 26.

    Corrigan PW, River LP, Lundin R, et al. Stigmatizing attributions about mental illness. J Community Psychol. 2000;28(1):91–102 2000.

    Article  Google Scholar 

  27. 27.

    Batey DS, Whitfield S, Mulla M, et al. Adaptation and implementation of an intervention to reduce HIV-related stigma among healthcare workers in the United States: piloting of the FRESH workshop. AIDS Patient Care STDs. 2016;30:519–27.

    Article  Google Scholar 

  28. 28.

    Bhana A, Mellins CA, Petersen I, et al. The VUKA family program: piloting a family-based psychosocial intervention to promote health and mental health among HIV infected early adolescents in South Africa. AIDS Care. 2014;26:1–11.

    Article  Google Scholar 

  29. 29.

    Bogart KR, Hemmesch AR. Benefits of support conferences for parents of and people with Moebius syndrome. Stigma Health. 2016;1:109–21.

    Article  Google Scholar 

  30. 30.

    Chidrawi HC, Greeff M, Temane QM, Doak CM. HIV stigma experiences and stigmatisation before and after an intervention. Health SA Gesondheid. 2016;21:196–205.

    Article  Google Scholar 

  31. 31.

    Hawke LD, Michalak EE, Maxwell V, Parikh SV. Reducing stigma toward people with bipolar disorder: impact of a filmed theatrical intervention based on a personal narrative. Int J Soc Psychiatry. 2014;60:741–50.

    Article  Google Scholar 

  32. 32.

    Henderson C, Corker E, Lewis-Holmes E, et al. England’s time to change antistigma campaign: one-year outcomes of service user-rated experiences of discrimination. Psychiatr Serv. 2012;63:451–7.

    Article  Google Scholar 

  33. 33.

    Maulik PK, Kallakuri S, Devarapalli S, Vadlamani VK, Jha V, Patel A. Increasing use of mental health services in remote areas using mobile technology: a pre-post evaluation of the SMART Mental Health project in rural India. J Glob Health. 2017;7(1).

  34. 34.

    Michalak E, Livingston J, Maxwell V, Hole R, Hawke L, Parikh S. Using theatre to address mental illness stigma: a knowledge translation study in bipolar disorder. Int J Bipolar Disorders. 2014;2(1):12.

    Article  Google Scholar 

  35. 35.

    Orkibi H, Bar N, Eliakim I. The effect of drama-based group therapy on aspects of mental illness stigma. Arts Psychother. 2014;41:458–66.

    Article  Google Scholar 

  36. 36.

    Pinfold V, Thornicroft G, Huxley P, Farmer P. Active ingredients in anti-stigma programmes in mental health. Int Rev Psychiatry. 2005;17:123–31.

    Article  Google Scholar 

  37. 37.

    Smith Fawzi MC, Eustache E, Oswald C, et al. Psychosocial support intervention for HIV-affected families in Haiti: implications for programs and policies for orphans and vulnerable children. Soc Sci Med. 2012;74:1494–503.

    Article  Google Scholar 

  38. 38.

    Snead K, Ackerson J, Bailey K, Schmitt MM, Madan-Swain A, Martin RC. Taking charge of epilepsy: the development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents. Epilepsy Behav. 2004;5:547–56.

    Article  Google Scholar 

  39. 39.

    Stuhlmiller CM. Breaking down the stigma of mental illness through an adventure camp: a collaborative education initiative. Australian e-J Advancement Mental Health. 2003;2:90–8.

    Article  Google Scholar 

  40. 40.

    Thurman T, Jarabi B, Rice J. Caring for the caregiver: evaluation of support groups for guardians of orphans and vulnerable children in Kenya. AIDS Care. 2012;24:811–9.

    Article  Google Scholar 

  41. 41.

    Uys L, Chirwa M, Kohi T, et al. Evaluation of a health setting-based stigma intervention in five African countries.(Author abstract). AIDS Patient Care STDs. 2009;23:1059.

    Article  Google Scholar 

  42. 42.

    Yotsumoto K, Hirose T, Hashimoto T. An awareness program: the significance of lectures delivered by individuals with mental disabilities. World Federation Occup Ther Bull. 2010;62:40–5.

    Article  Google Scholar 

Download references


This article is part of a collection that draws upon a 2017 workshop on stigma research andglobal health, which was organized by the Fogarty International Center, National Institute of Health,United States. The article was supported by a generous contribution by the Fogarty InternationalCenter.


DR is supported by the University of Washington/Fred Hutch Center for AIDS Research, an NIH-funded program under award number AI027757 which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, and NIDDK. Fogarty International Center supported the publication of this manuscript through its conceptualization as a topic, convening authors, and providing funds for its publication. Content is the responsibility of the authors and does not represent the views of the National Institutes of Health, Fogarty International Center, or associated funders.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Author information




DR analyzed and interpreted data, completed the first draft of the paper, and incorporated co-author feedback. AE analyzed and interpreted data; drafted portions of the paper, table, and figures; and provided critical feedback on drafts of the manuscript. MN designed the analysis, analyzed and interpreted data, and provided critical feedback on drafts of the manuscript. MH contributed to framing, drafted portions of the paper, and provided critical feedback on drafts of the manuscript. SF analyzed and interpreted data and provided critical feedback on drafts of the manuscript. VG analyzed and interpreted data and provided critical feedback on drafts of the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Deepa Rao.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rao, D., Elshafei, A., Nguyen, M. et al. A systematic review of multi-level stigma interventions: state of the science and future directions. BMC Med 17, 41 (2019).

Download citation


  • Stigma
  • Multi-level interventions
  • Low- and middle-income countries